Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Heron Therapeutics (HRTX) Asset Utilization Ratio (2016 - 2025)

Heron Therapeutics' Asset Utilization Ratio history spans 12 years, with the latest figure at 0.61 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 3.47% year-over-year to 0.61; the TTM value through Dec 2025 reached 0.61, down 3.47%, while the annual FY2025 figure was 0.63, 0.03% changed from the prior year.
  • Asset Utilization Ratio reached 0.61 in Q4 2025 per HRTX's latest filing, down from 0.64 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.64 in Q3 2025 to a low of 0.23 in Q3 2021.
  • Average Asset Utilization Ratio over 5 years is 0.48, with a median of 0.56 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: dropped 15.87% in 2021, then skyrocketed 67.06% in 2022.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.26 in 2021, then skyrocketed by 56.94% to 0.41 in 2022, then soared by 36.59% to 0.56 in 2023, then increased by 13.02% to 0.64 in 2024, then decreased by 3.47% to 0.61 in 2025.
  • Per Business Quant, the three most recent readings for HRTX's Asset Utilization Ratio are 0.61 (Q4 2025), 0.64 (Q3 2025), and 0.64 (Q2 2025).